Will we rue letting genie out of bottle with gene therapy to make babies?
RAPID advances in human fertility treatment and the penchant of some scientists to push the envelope are creating ethical dilemmas among policymakers around the world.
Earlier this year, a Greek woman gave birth to a boy through a treatment that combined the DNA from three people.
He is not the first of his kind but what made his birth a talking point was that his mother was not trying to stop the transmission of defective DNA to her child. Instead, he is a product of infertility treatment. To understand the difference, let's back up a little.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Columns
‘Competition for talent’ a poor excuse to keep key executives’ pay under wraps
OCBC should put its properties into a Reit and distribute the trust’s units to shareholders
Why a stronger US dollar is dangerous
An overstimulated US economy is asking for trouble
Too many property agents? Cap commissions on home sales
Time to study broadening of private market access